Graham E. Blakey
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
- Pharmacogenetics and Drug Metabolism
- Toxicology top 5%
Papers in
-
- Cannabis and Cannabinoid Research 3
- Pharmacogenetics and Drug Metabolism 2
-
- Epilepsy research and treatment 3
- Co-authors
- Gilmour Morrison (3 shared papers)Lesley Taylor (1 shared paper)Bola Tayo (1 shared paper)Barry E. Gidal (1 shared paper)Kenneth William Sommerville (2 shared papers)Julie C. Crockett (1 shared paper)Malcolm Rowland (2 shared papers)Ivan A. Nestorov (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Neurology (1 paper)Journal of Biopharmaceutical Statistics (1 paper)CNS Drugs (1 paper)Pediatric Neurology (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Graham E. Blakey
12 papers receiving 717 citations
Graham E. Blakey's Hit Papers
Peers
Comparison fields: 5 of 86
- Pharmacology 498
- Pharmacology 112
- Toxicology 38
- Psychiatry and Mental health 125
- Statistics and Probability 51
Countries citing papers authored by Graham E. Blakey
This map shows the geographic impact of Graham E. Blakey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham E. Blakey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham E. Blakey more than expected).
Fields of papers citing papers by Graham E. Blakey
This network shows the impact of papers produced by Graham E. Blakey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham E. Blakey. The network helps show where Graham E. Blakey may publish in the future.
Co-authors
The 25 scholars most cited alongside Graham E. Blakey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects Hit paper breakdown → | 2018 | 374 |
| 2 | 2019 | 180 | |
| 3 | 1997 | 78 | |
| 4 | 2003 | 60 | |
| 5 | 2005 | 26 | |
| 6 | 2004 | 17 | |
| 7 | 1999 | 4 | |
| 8 | 2013 | 2 | |
| 9 | 2001 | 2 | |
| 10 | 1996 | 1 | |
| 11 | 2001 | 1 | |
| 12 | 2018 | 1 |
About Graham E. Blakey
Graham E. Blakey is a scholar working on Pharmacology, Psychiatry and Mental health, Pharmacology, Statistics and Probability and Management Science and Operations Research, having authored 12 papers that have together received 746 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (3 papers), Epilepsy research and treatment (3 papers), Statistical Methods in Clinical Trials (2 papers), Analytical Chemistry and Chromatography (2 papers), Optimal Experimental Design Methods (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Pharmacology (498 citations), Pharmacology (112 citations), Toxicology (38 citations), Psychiatry and Mental health (125 citations) and Statistics and Probability (51 citations). Graham E. Blakey has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Gilmour Morrison, Lesley Taylor, Bola Tayo, Barry E. Gidal, Kenneth William Sommerville, Julie C. Crockett, Malcolm Rowland, Ivan A. Nestorov, Leon J Aarons and J. Andrew Lockton. Their work appears in journals such as British Journal of Clinical Pharmacology, Neurology, Journal of Biopharmaceutical Statistics, CNS Drugs and Pediatric Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.